Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 74801-74850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05766527
A Study of KM602 in Patients With Advanced Solid Tumors
PHASE1Not yet recruiting
38 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05828251
Full Thickness Macular Hole; Should it be Handled Subacutely?
NARecruiting
56 participants
Started: Apr 30, 2023 · Completed: Apr 1, 2028
1 condition1 sponsor1 location
NCT05834855
Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
PHASE3Recruiting
200 participants
Started: Apr 30, 2023 · Completed: May 31, 2027
6 conditions2 sponsors1 location
NCT05830227
Evaluation of Infrared Thermal Imaging in Diagnosis of OSAHS in Children
N/ARecruiting
80 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05847907
RCT KS-SA Versur KS-BA in Diabetic Patients
NANot yet recruiting
50 participants
Started: Apr 30, 2023 · Completed: Jan 30, 2028
2 conditions6 sponsors1 location
NCT06344650
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
N/ARecruiting
100 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2026
1 condition3 sponsors1 location
NCT05273112
Evaluation of the Variation in Quality of Life During Medical Transition for Transgender People.
N/ANot yet recruiting
400 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2030
1 condition1 sponsor13 locations
NCT05813665
A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone
PHASE3Not yet recruiting
146 participants
Started: Apr 30, 2023 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT05918094
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE3Recruiting
540 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor10 locations
NCT05758844
The Safe-line Technique as Additional Attempt to Mitigate Spinal Cord Ischemia After Endovascular Exclusion of TAAA
N/ARecruiting
100 participants
Started: Apr 30, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05777226
Research of SORD-CMT Natural History and Epalrestat Treatment
PHASE2Not yet recruiting
30 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor0 locations
NCT05614466
The SIMPLY-B Study
NANot yet recruiting
100 participants
Started: Apr 30, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor0 locations
NCT05828225
Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis
PHASE1Recruiting
9 participants
Started: Apr 30, 2023 · Completed: Apr 20, 2026
1 condition1 sponsor1 location
NCT05804864
A Study of KM501 in Patients With Solid Tumors
PHASE1Not yet recruiting
96 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05716646
In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease
N/ANot yet recruiting
50 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2028
4 conditions1 sponsor0 locations
NCT05822453
Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma
PHASE2Not yet recruiting
20 participants
Started: Apr 30, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05617859
Lenvatinib for Advanced Bone and Soft Tissue Sarcoma
PHASE2Recruiting
60 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05825053
Retaining Short-term Training Effects on Gait Adaptability in People With Stroke
NANot yet recruiting
75 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06167603
Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories
N/ARecruiting
140 participants
Started: Apr 30, 2023 · Completed: Apr 1, 2026
1 condition2 sponsors1 location
NCT05732662
SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC
PHASE2Not yet recruiting
25 participants
Started: Apr 30, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT05353452
Collaborative Care in Posttraumatic Epilepsy
NARecruiting
60 participants
Started: Apr 30, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06514690
Postoperative Memories and Level of Sedation for Tracheal Intubation Using Fiberoptic Bronchoscopy/Videolaryngoscopy
N/ARecruiting
100 participants
Started: Apr 29, 2023 · Completed: May 29, 2025
3 conditions1 sponsor2 locations
NCT05866640
Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
EARLY_PHASE1Recruiting
10 participants
Started: Apr 29, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT05989386
Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies
PHASE2/PHASE3Recruiting
200 participants
Started: Apr 29, 2023 · Completed: Dec 29, 2025
8 conditions1 sponsor1 location
NCT05720507
Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty
NARecruiting
36 participants
Started: Apr 29, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05853068
Assessment of PaO2/FiO2 Ratio Pre and POst INTubation
N/AActive, not recruiting
400 participants
Started: Apr 29, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors2 locations
NCT05930184
Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy
PHASE2/PHASE3Recruiting
98 participants
Started: Apr 29, 2023 · Completed: Dec 31, 2024
6 conditions1 sponsor1 location
NCT05688696
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
PHASE2Recruiting
186 participants
Started: Apr 29, 2023 · Completed: May 30, 2026
1 condition1 sponsor41 locations
NCT06432179
Hospice Volunteer Community,Dying Patient Prepare Spirtal Care
N/AActive, not recruiting
30 participants
Started: Apr 29, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06169631
The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology
NARecruiting
100 participants
Started: Apr 29, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT06297538
Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation
NARecruiting
84 participants
Started: Apr 29, 2023 · Completed: Apr 29, 2026
1 condition3 sponsors1 location
NCT05805306
Entre Herman@s: Promoting Health Among Latino MSM
NAActive, not recruiting
288 participants
Started: Apr 29, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05698628
Distal Perfusion Timing, Early or Conservative, to Prevent Limb Ischemia During Peripheral VA-ECMO
NARecruiting
400 participants
Started: Apr 28, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05615636
A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
PHASE2Recruiting
36 participants
Started: Apr 28, 2023 · Completed: Aug 19, 2027
3 conditions1 sponsor1 location
NCT05724394
Feasibility Trial of Getting Better Bite by Bite for Eating Disorders
NAActive, not recruiting
84 participants
Started: Apr 28, 2023 · Completed: Dec 30, 2024
3 conditions1 sponsor1 location
NCT05626608
Continuous Electrical Neuromodulation of the Globus Pallidus Intern in Parkinson's Disease by the Directional Electrode CARTESIA™
NARecruiting
10 participants
Started: Apr 28, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05788120
Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock
N/ARecruiting
600 participants
Started: Apr 28, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06695416
Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX
N/ARecruiting
500 participants
Started: Apr 28, 2023 · Completed: Apr 28, 2025
2 conditions1 sponsor1 location
NCT05838131
Study of CT071 Injection in RRMM or PPCL
EARLY_PHASE1Active, not recruiting
20 participants
Started: Apr 28, 2023 · Completed: Jul 31, 2025
2 conditions2 sponsors1 location
NCT05866783
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
N/ARecruiting
500 participants
Started: Apr 28, 2023 · Completed: Jan 1, 2038
4 conditions4 sponsors1 location
NCT05835245
Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)
PHASE2Recruiting
30 participants
Started: Apr 28, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05843305
A Study of BPI-452080 in Subjects With Solid Tumors
PHASE1Not yet recruiting
87 participants
Started: Apr 28, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor5 locations
NCT04991870
Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
PHASE1Recruiting
25 participants
Started: Apr 28, 2023 · Completed: Jan 31, 2027
3 conditions2 sponsors1 location
NCT06114082
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma
PHASE2Recruiting
128 participants
Started: Apr 28, 2023 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06823102
Brain Connectivity Analysis
NAActive, not recruiting
75 participants
Started: Apr 28, 2023 · Completed: Apr 27, 2026
1 condition1 sponsor1 location
NCT06202235
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
N/ARecruiting
100 participants
Started: Apr 28, 2023 · Completed: Dec 8, 2026
1 condition1 sponsor1 location
NCT05205980
Perturbation Training Reduces Falls in People With AD
NARecruiting
30 participants
Started: Apr 28, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05799287
A Study of Telitacicept in Patients With Primary Immunoglobulin A(IgA) Nephropathy
PHASE3Active, not recruiting
318 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor101 locations
NCT05761028
A Study of CM310 in Subjects With Moderate to Severe Asthma
PHASE2/PHASE3Recruiting
600 participants
Started: Apr 28, 2023 · Completed: May 31, 2032
1 condition1 sponsor1 location
NCT05869227
Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
166 participants
Started: Apr 28, 2023 · Completed: Dec 20, 2027
2 conditions3 sponsors1 location